Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis
- PMID: 3117625
- PMCID: PMC1433134
- DOI: 10.1136/gut.28.8.1002
Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis
Abstract
The long chain fatty acid composition of phospholipids in colonic mucosa was determined by high performance liquid chromatography in nine patients with active ulcerative colitis and eight healthy controls. The arachidonic acid composition was 12.5 +/- 1.4 mol % (mean +/- 2 SEM) in the inflamed colonic mucosa from the patients with active ulcerative colitis and 6.8 +/- 1.2 mol % in the intact mucosa from healthy controls (p less than 0.001). In the inflamed colonic mucosa, oleic acid and palmitoleic acid were concomitantly decreased (p less than 0.001 and p less than 0.02, respectively), while docosahexaenoic acid was increased (p less than 0.05). Histopathological examination showed that there was a three fold increase in the cell density of inflammatory infiltrate in the lamina propria of the inflamed colonic mucosa (p less than 0.001). The cell density of inflammatory infiltrate correlated with the arachidonic acid composition of phospholipids in colonic mucosa (r = 0.89, p less than 0.005). These findings indicate that inflammation alters the long chain fatty acid composition of phospholipids in colonic mucosa. The observed increase in the arachidonic acid composition of phospholipids in inflamed colonic mucosa may contribute to the enhanced arachidonic acid metabolism in patients with active ulcerative colitis.
Similar articles
-
Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease.Clin Sci (Lond). 1987 Oct;73(4):361-4. doi: 10.1042/cs0730361. Clin Sci (Lond). 1987. PMID: 3665357
-
Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity.J Crohns Colitis. 2014 Jan;8(1):70-9. doi: 10.1016/j.crohns.2013.03.013. Epub 2013 Apr 23. J Crohns Colitis. 2014. PMID: 23619007
-
Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.Hepatogastroenterology. 2002 Jan-Feb;49(43):116-23. Hepatogastroenterology. 2002. PMID: 11941933
-
Can ulcerative colitis be cured?Discov Med. 2019 May;27(149):197-200. Discov Med. 2019. PMID: 31361982 Review.
-
Mucin histochemistry of the colon.Curr Top Pathol. 1976;63:143-78. doi: 10.1007/978-3-642-66481-6_5. Curr Top Pathol. 1976. PMID: 795613 Review. No abstract available.
Cited by
-
Bromophenacyl bromide, a phospholipase A2 inhibitor attenuates chemically induced gastroduodenal ulcers in rats.World J Gastroenterol. 2006 Sep 28;12(36):5798-804. doi: 10.3748/wjg.v12.i36.5798. World J Gastroenterol. 2006. PMID: 17007045 Free PMC article.
-
Detection of inflammatory bowel disease by proton magnetic resonance spectroscopy (1H MRS) using an animal model.J Inflamm (Lond). 2007 Nov 26;4:24. doi: 10.1186/1476-9255-4-24. J Inflamm (Lond). 2007. PMID: 18039383 Free PMC article.
-
Ferroptosis in colorectal cancer: a future target?Br J Cancer. 2023 Apr;128(8):1439-1451. doi: 10.1038/s41416-023-02149-6. Epub 2023 Jan 26. Br J Cancer. 2023. PMID: 36703079 Free PMC article. Review.
-
Mechanism of action of 5-arninosalicylic acid.Mediators Inflamm. 1992;1(3):151-65. doi: 10.1155/S0962935192000243. Mediators Inflamm. 1992. PMID: 18475455 Free PMC article.
-
The metabolic nature of inflammatory bowel diseases.Nat Rev Gastroenterol Hepatol. 2022 Dec;19(12):753-767. doi: 10.1038/s41575-022-00658-y. Epub 2022 Jul 29. Nat Rev Gastroenterol Hepatol. 2022. PMID: 35906289 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical